ADVANCED OR METASTATIC SOLID TUMORS
Clinical trials for ADVANCED OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early test of easier cancer shot underway
Disease control OngoingThis early-stage study is testing a new way to give a cancer drug called pembrolizumab as an injection under the skin, instead of through an IV. It involves 72 people with advanced solid tumors. The main goals are to see how much of the drug gets into the bloodstream this way, an…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New pill targets advanced cancers in first human tests
Disease control OngoingThis is an early-stage study to test the safety and find the right dose of a new oral drug called ERAS-601. It will be given to about 90 adults with advanced solid tumors that have spread, both by itself and combined with other cancer therapies. The main goals are to see how much…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New Two-Drug attack targets Tough-to-Treat cancer mutation
Disease control OngoingThis study is testing the safety and early effectiveness of a new drug combination (naporafenib plus trametinib) for people with advanced solid tumors that have a specific genetic change called a RAS Q61X mutation. It is for patients aged 12 and older whose cancer has grown despi…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New cancer drug seeks right dose to fight tough tumors
Disease control OngoingThis early-stage trial is testing a new drug called WTX-330 in adults with advanced solid tumors or non-Hodgkin lymphoma that have stopped responding to standard treatments. The main goals are to find the safest and most effective dose and to see if the drug can shrink tumors. Re…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Werewolf Therapeutics, Inc. • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC